Dr Leonard Michael Tyko Ii, DDS, MD | |
1174 Montgomery Dr, Santa Rosa, CA 95405-4818 | |
(707) 545-4625 | |
Not Available |
Full Name | Dr Leonard Michael Tyko Ii |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 1174 Montgomery Dr, Santa Rosa, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770626921 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223S0112X | Dentist - Oral And Maxillofacial Surgery | OMS031 (California) | Primary |
208D00000X | General Practice | A71195 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Leonard Michael Tyko Ii, DDS, MD 1174 Montgomery Dr, Santa Rosa, CA 95405-4818 Ph: (707) 545-4625 | Dr Leonard Michael Tyko Ii, DDS, MD 1174 Montgomery Dr, Santa Rosa, CA 95405-4818 Ph: (707) 545-4625 |
News Archive
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report findings that show that in women with acute postpartum anemia, due to excessive blood loss during delivery, red blood cell transfusion led to a statistically significant decrease in physical fatigue.
Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended March 31, 2012 (1Q12) of $1.49, compared to $1.86 per share for the quarter ended March 31, 2011 (1Q11). The company had previously anticipated earnings per share in the range of $1.35 to $1.45 for 1Q12.
Patients with inflammatory bowel disease (IBD) who take medications as directed have decreased medical costs, researchers from the University of Chicago researchers report at the American College of Gastroenterology annual scientific meeting in Las Vegas. A second study from the same group, however, suggests that there is no simple way to improve compliance.
Merck, known as MSD outside the United States and Canada, and Inspire Pharmaceuticals, Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR") has expired in connection with the previously announced cash tender offer made by Monarch Transaction Corp., a wholly owned subsidiary of Merck, to purchase all of the outstanding shares of common stock of Inspire.
› Verified 6 days ago